Literature DB >> 3033089

Molecular epidemiology of adenovirus type 35 infections in immunocompromised hosts.

P R Flomenberg, M Chen, G Munk, M S Horwitz.   

Abstract

Adenovirus type 35 (Ad35) is an uncommon group B adenovirus that has been isolated nearly exclusively from immunosuppressed hosts. In our series of 46 patients with Ad35 isolates, 36 had AIDS or AIDS-related complex (ARC), seven patients were immunocompromised because of other diseases, and three patients were "normal." Neither patients with AIDS or ARC made specific antibody to Ad35, whereas antibody was present in one immunocompetent host and one renal transplant recipient. All isolates were identified as Ad35 by using genomic analysis with the restriction endonuclease SmaI, but many viruses exhibited other group B hemagglutinins, a property of the fiber protein. Further analysis of DNAs from 40 of these isolates, mapped by using the enzymes BamHI, HpaI, and PstI, revealed a total of 14 genomic variants from the Ad35 prototype. Seven of these genomic types, with either Ad7 or Ad11 hemagglutinin, had corresponding restriction site differences within the fiber gene, a result consistent with recombination events with other group B adenoviruses.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3033089     DOI: 10.1093/infdis/155.6.1127

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Efficient gene transfer into human CD34(+) cells by a retargeted adenovirus vector.

Authors:  D M Shayakhmetov; T Papayannopoulou; G Stamatoyannopoulos; A Lieber
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

2.  Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity.

Authors:  Ronald Vogels; David Zuijdgeest; Richard van Rijnsoever; Eric Hartkoorn; Irma Damen; Marie-Pierre de Béthune; Stefan Kostense; Germaine Penders; Niels Helmus; Wouter Koudstaal; Marco Cecchini; Antoinette Wetterwald; Mieke Sprangers; Angelique Lemckert; Olga Ophorst; Björn Koel; Michelle van Meerendonk; Paul Quax; Laura Panitti; Jos Grimbergen; Abraham Bout; Jaap Goudsmit; Menzo Havenga
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

3.  Role of the adenovirus E3-19k conserved region in binding major histocompatibility complex class I molecules.

Authors:  P Flomenberg; J Szmulewicz; E Gutierrez; H Lupatkin
Journal:  J Virol       Date:  1992-08       Impact factor: 5.103

4.  Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States.

Authors:  Edward Nwanegbo; Eftyhia Vardas; Wentao Gao; Hilton Whittle; Huijie Sun; David Rowe; Paul D Robbins; Andrea Gambotto
Journal:  Clin Diagn Lab Immunol       Date:  2004-03

5.  Sequence and genetic organization of adenovirus type 35 early region 3.

Authors:  P R Flomenberg; M Chen; M S Horwitz
Journal:  J Virol       Date:  1988-11       Impact factor: 5.103

6.  Characterization of a major histocompatibility complex class I antigen-binding glycoprotein from adenovirus type 35, a type associated with immunocompromised hosts.

Authors:  P R Flomenberg; M Chen; M S Horwitz
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

Review 7.  Pediatric human immunodeficiency virus infection.

Authors:  J B Domachowske
Journal:  Clin Microbiol Rev       Date:  1996-10       Impact factor: 26.132

8.  Epitopes and hemagglutination binding domain on subgenus B:2 adenovirus fibers.

Authors:  Y F Mei; G Wadell
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

9.  Characterization of human adenovirus 35 and derivation of complex vectors.

Authors:  Duncan McVey; Mohammed Zuber; Damodar Ettyreddy; Christopher D Reiter; Douglas E Brough; Gary J Nabel; C Richter King; Jason G D Gall
Journal:  Virol J       Date:  2010-10-19       Impact factor: 4.099

10.  Sequential adenovirus infection of type 14 hemorrhagic cystitis and type 35 generalized infection after cord blood transplantation.

Authors:  Takashi Abe; Tatsuo Furukawa; Masayoshi Masuko; Atsunori Sugimoto; Kiyoshi Okazuka; Keiichiro Honma; Takeo Fujimura; Seitaro Iguchi; Shinichi Nishi; Mitsuhiro Ueno; Masayuki Nagahashi; Gen Watanabe; Yoichi Ajioka; Noriatsu Isahai; Koichi Nagai; Yukumasa Kazuyama; Yosifusa Aizawa
Journal:  Int J Hematol       Date:  2009-09-11       Impact factor: 2.490

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.